EDGAR Filing Documents for 0001144204-16-125431

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:

SEC Accession No. 0001144204-16-125431

Filing Date

2016-09-27

Accepted

2016-09-27 08:45:31

Documents

Period of Report

2016-09-27

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 6-K	v449494_6k.htm	6-K	10427
2	EXHIBIT 99.1	v449494_ex99-1.htm	EX-99.1	61072
3	EXHIBIT 99.2	v449494_ex99-2.htm	EX-99.2	415448
	Complete submission text file	0001144204-16-125431.txt		487923

Mailing Address 5 HACHAROSHET ST. RAANANA L3 4365603

Business Address XTL BIOPHARMACEUTICALS LTD C/O ALSTON & BIRD LLP, 90 PARK AVENUE NEW YORK NY 10016 972 9 955 7080

XTL BIOPHARMACEUTICALS LTD (Filer) CIK: 0001023549 (see all company filings)

IRS No.: 000000000
Type: 6-K | Act: 34 | File No.: 001-36000 | Film No.: 161903393
SIC: 2834 Pharmaceutical Preparations